The DOI matches its Crossref record; the references it cites are not checked yet.
Glucagon Receptor Signaling Regulates Energy Metabolism via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21
Open accessAbstract
Glucagon, an essential regulator of glucose and lipid metabolism, also promotes weight loss, in part through potentiation of fibroblast growth factor 21 (FGF21) secretion. However, FGF21 is only a partial mediator of metabolic actions ensuing from glucagon receptor (GCGR) activation, prompting us to search for additional pathways. Intriguingly, chronic GCGR agonism increases plasma bile acid levels. We hypothesized that GCGR agonism regulates energy metabolism, at least in part, through farnesoid X receptor (FXR). To test this hypothesis, we studied whole-body and liver-specific FXR-knockout (Fxr∆liver) mice. Chronic GCGR agonist (IUB288) administration in diet-induced obese (DIO) Gcgr, Fgf21, and Fxr whole-body or liver-specific knockout (∆liver) mice failed to reduce body weight when compared with wild-type (WT) mice. IUB288 increased energy expenditure and respiration in DIO WT mice, but not Fxr∆liver mice. GCGR agonism increased [14C]palmitate oxidation in hepatocytes isolated from WT mice in a dose-dependent manner, an effect blunted in hepatocytes from Fxr∆liver mice. Our data clearly demonstrate that control of whole-body energy expenditure by GCGR agonism requires intact FXR signaling in the liver. This heretofore-unappreciated aspect of glucagon biology has implications for the use of GCGR agonism in the therapy of metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies in preclinical models demonstrate the potential for GcgR agonism to induce weight loss either alone [54,55] or in combination with GLP-1R and/or GIPR agonism [43].”
From Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice (2022) · cites this paper as [54]
The cited source says what the claim attributes to it.
In the citing paper
“This is consistent with the known role of GLP-1R [49,60] and GIPR [37,38] agonism to reduce food intake, primarily but not exclusively via CNS mediated signaling events, and GcgR agonism to induce energy expenditure [54] through mechanisms that are not fully described.”
From Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice (2022) · cites this paper as [54]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“With respect to GIPR agonism, while a definitive mechanism in how GIPR signaling impacts energy balance is yet to be reported, GIPR activation has been associated with improved adipose tissue health41,106,123,171.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 53 · Cited by 97
Metadata
- Authors
- Kim, T., Nason, S., Holleman, C., Pepin, M., Wilson, L., Berryhill, T. F., Wende, A. R., Steele, C., Young, M. E., Barnes, S., Drucker, D. J., Finan, B., DiMarchi, R., Perez-Tilve, D., Tschöp, M., & Habegger, K. M.
- Affiliations
- University of Alabama at Birmingham (US)
- University of Toronto (CA)
- Novo Nordisk Research Center Indianapolis, Indianapolis, IN
- Indiana University Bloomington (US)
- Division of Endocrinology, Diabetes and Metabolism, Metabolic Diseases Institute, University of Cincinnati, Cincinnati, OH
- Helmholtz Munich (DE)
- Corresponding author
- Habegger, Kirk M.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2018-06-20
- Volume
- 67
- Issue
- 9
- Pages
- 1773-1782
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC6110317
- OpenAlex
- W2809364083
- Cited by
- 97
- References
- 53
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 18 · 2023: 6 · 2022: 11 · 2021: 12 · 2020: 8 · 2019: 15 · 2018: 1
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Site cant be reached (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- National Institutes of Health (5K01-DK-098319, 1R01-DK-112934, R01-DK-077975, P30-DK-079626)
- National Institute of Diabetes and Digestive and Kidney Diseases
- American Diabetes Association (1-13-JF-21)
- Canadian Institutes of Health Research (136942, 154321)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glucagon receptor, farnesoid X receptor, FGF21, energy metabolism, energy expenditure, diet-induced obesity, bile acids, liver-specific knockout mice, weight loss, metabolic disorders
- MeSH terms
- Receptor, Farnesoid X-Activated, Animals, Calorimetry, Indirect, Cells, Cultured, Energy Metabolism, Fibroblast Growth Factors, Gene Expression Regulation, Liver, Male, Mice, Inbred C57BL, Mitochondria, Liver, Obesity, Organ Specificity, Oxidative Phosphorylation, Peptides, Signal Transduction, Weight Gain, Receptors, Glucagon, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Anti-Obesity Agents, Adiposity, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucagon Receptor Signaling Regulates Energy Metabolism via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21. https://app.cochat.ai/papers/10.2337/db17-1502
- The paper
- Kim, T., Nason, S., Holleman, C., Pepin, M., Wilson, L., Berryhill, T. F., Wende, A. R., Steele, C., Young, M. E., Barnes, S., Drucker, D. J., Finan, B., DiMarchi, R., Perez-Tilve, D., Tschöp, M., & Habegger, K. M. (2018). Glucagon Receptor Signaling Regulates Energy Metabolism via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21. Diabetes. https://doi.org/10.2337/db17-1502
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.